Research graph
References from Inflammatory Biomarker Combination in Multivessel Coronary Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Targeting the NLRP3 inflammasome in cardiovascular diseases
10.1016/j.pharmthera.2021.108053 · 2022 · External reference
10.1016/j.jacasi.2026.06.040 · 2026 · Admitted local publication
The NLRP3 inflammasome in kidney disease and autoimmunity
10.1111/nep.12785 · 2016 · External reference
NLRP3 inflammasomes: dual function in infectious diseases
10.4049/jimmunol.2300745 · 2024 · External reference
Antiinflammatory therapy with canakinumab for atherosclerotic disease
10.1056/nejmoa1707914 · 2017 · External reference
Efficacy and safety of low-dose colchicine after myocardial infarction
10.1056/nejmoa1912388 · 2019 · External reference
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1beta inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
10.1093/eurheartj/ehz542 · 2020 · External reference
